Advances in the topical treatment of diabetic foot Ulcers

Current Diabetes Reviews

Volumn 8, Issue 3, 2012, Pages 209-218

  Papanas, N ^a   Eleftheriadou, I ^b   Tentolouris, N ^b   Maltezos, E ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Diabetes mellitus; Diabetic foot; Treatment; Wound healing

Indexed keywords

AMELOGENIN; CITRIC ACID; DERMAX; DOXYCYCLINE; E MATRIX; HYALOFILL; HYALURONIC ACID DERIVATIVE; LAMIN GEL; LYOPHILIZED COLLAGEN; METAL ION; PLATELET DERIVED GROWTH FACTOR; PROMOGRAN; SCLEROPROTEIN; UNCLASSIFIED DRUG; VULNAMIN GEL; WOUND HEALING PROMOTING AGENT; XELMA;

ANGIOGENESIS; ANKLE BRACHIAL INDEX; AUTOLOGOUS DERMAL GRAFT; BLOOD PRESSURE MEASUREMENT; COMPRESSION BANDAGE; COST EFFECTIVENESS ANALYSIS; DEBRIDEMENT; DIABETIC FOOT; DIABETIC NEUROPATHY; FIBROBLAST; GRANULATION TISSUE; HUMAN; KERATINOCYTE; LEG ULCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN GRAFT; STAPHYLOCOCCUS INFECTION; TISSUE ENGINEERING; TOE BRACHIAL INDEX; TREATMENT DURATION; TREATMENT INDICATION; ULCER HEALING; WOUND CARE; WOUND CLOSURE; WOUND DRESSING;

ADMINISTRATION, TOPICAL; AMPUTATION; COLLAGEN; DEBRIDEMENT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; FEMALE; HUMANS; MALE; SKIN, ARTIFICIAL; TREATMENT OUTCOME; WOUND HEALING;

EID: 84861173027     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339912800563963     Document Type: Review

References (50)

1. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. Theglobal burden of diabetic foot disease. Lancet 2005; 366: 1719-24.
2. Papanas N, Maltezos E. The diabetic foot: established and emerging treatments. Acta Clin Belg 2007; 62: 230-8.
3. Reiber G, Ledoux WR. Epidemiology of diabetic foot ulcers and complications: evidence for prevention. In: Williams R, Herman W, Kinmoth AL, Wareham NJ, Eds. The evidence base for diabetes care, Wiley, Chichester 2002; pp. 641-65.
4. Papanas N, Maltezos E, Edmonds M. St. Vincent declaration after15 years or who cleft the devil's foot? Vasa 2006; 35: 3-4.
5. Bakker K, Foster AVM, van Houtum WH, Riley P. International Diabetes Federation and International Working Group of the Diabetic Foot. Time to act. The Netherlands 2005.
6. Jeffcoate WJ, van Houtum WH. Amputation as a marker of the quality of foot care in diabetes. Diabetologia 2004; 47: 2051-8.
7. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Healing diabetic neuropathic foot ulcers: are we getting better? Diabet Med 2005; 22: 172-6.
8. Jude EB, Blakytny R, Bulmer J, Boulton AJ, Ferguson MW. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabet Med 2002; 19: 440-7.
9. Blakytny R, Jude E. Altered molecular mechanisms of diabetic foot ulcers. Int J Low Extrem Wounds 2009; 8: 95-104.
10. Lobmann R, Schultz G, Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 2005; 28: 461-71.
11. Chao CY, Cheing GL. Microvascular dysfunction in diabetic foot disease and ulceration. Diabetes Metab Res Rev 2009; 25: 604-14.
12. Shen JT, Falanga V. Innovative therapies in wound healing. J Cutan Med Surg 2003; 7: 217-24.
13. Petrova N, Edmonds M. Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs 2006; 11: 709-24.
14. Papanas N, Maltezos E. Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises? Int J Low Extrem Wounds 2007; 6: 37-53.
15. Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996; 19: 350-4.
16. Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003; 26: 1701-5.
17. Hanft JR, Surprenant MS. Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis. J Foot Ankle Surg 2002; 41: 291-9.
18. Newton DJ, Khan F, Belch JJ, Mitchell MR, Leese GP. Blood flow changes in diabetic foot ulcers treated with dermal replacement therapy. J Foot Ankle Surg 2002; 41: 233-7.
19. Browne AC, Vearncombe M, Sibbald RG. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft. Ostomy Wound Manage 2001; 47: 44-9.
20. Allenet B, Paree F, Lebrun T, et al. Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the French context. Diabetes Metab 2000; 26: 125-32.
21. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001; 24: 290-5.
22. Steinberg JS, Edmonds M, Hurley DP, King WN. Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers. J Am Podiatr Med Assoc 2010;100: 73-7.
23. Sams HH, Chen J, King LE. Graftskin treatment of difficult to heal diabetic foot ulcers: one center's experience. Dermatol Surg 2002;28: 698-703.
24. Edmonds M. Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds 2009; 8: 11-8.
25. Lipkin S, Chaikof E, Isseroff Z, Silverstein P. Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers: results of a multicenter pilot trial. Wounds 2003; 15: 230-36.
26. Moustafa M, Simpson C, Glover M, et al. A new autologous keratinocyte dressing treatment for non-healing diabetic neuropathic foot ulcers. Diabet Med 2004; 21: 786-9.
27. Lobmann R, Pittasch D, Muhlen I, Lehnert H. Autologous human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid for grafting in nonhealing diabetic foot lesions: apilot study. J Diabetes Complications 2003; 17: 199-204.
28. Cavallini M. Autologous fibroblasts to treat deep and complicated leg ulcers in diabetic patients. Wound Repair Regen 2007; 15: 35-8.
29. Caravaggi C, De Giglio R, Pritelli C, et al. HYAFF 11-based autologous dermal and epidermal grafts in the treatment ofnoninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care 2003; 26: 2853-9.
30. Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel fordiabetic ulcers. Adv Skin Wound Care 2005; 18: 258-66.
31. Martin BR, Sangalang M, Wu S, Armstrong DG. Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience. Int Wound J 2005; 2: 161-5.
32. Brigido SA. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective16-week pilot study. Int Wound J 2006; 3: 181-7.
33. Vazquez JR, Short B, Findlow AH, et al. Outcomes of hyaluronan therapy in diabetic foot wounds. Diabetes Res Clin Pract 2003; 59:123-7.
34. Marston WA, Usala A, Hill RS, Mendes R, Minsley MA. Initial report of the use of an injectable porcine collagen-derived matrix to stimulate healing of diabetic foot wounds in humans. Wound Repair Regen 2005; 13: 243-7.
35. Di Mauro C, Ossino AM, Trefiletti M, Polosa P, Beghe F. Lyophilized collagen in the treatment of diabetic ulcers. Drugs Exp Clin Res 1991; 17: 371-3.
36. Abbruzzese L, Rizzo L, Fanelli G, et al. Effectiveness and safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: a prospective double-blind randomized trial. Int J Low Extrem Wounds 2009; 8: 134-40.
37. Romanelli M, Dini V, Vowden P, Agren MS. Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: experimental and clinical evidence. Clin Interv Aging 2008; 3: 263-72.
38. Chin GA, Thigpin TG, Perrin KJ, Moldawer LL, Schultz GS. Treatment of chronic ulcers in diabetic patients with a topical metalloproteinase inhibitor, doxycycline. Wounds 2003; 15: 315-23.
39. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 2002; 137: 822-7.
40. Kakagia DD, Kazakos KJ, Xarchas KC, et al. Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial. J Diabetes Complications 2007; 21: 387-91.
41. Ghatnekar O, Willis M, Persson U. Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four Europeancountries. J Wound Care 2002; 11: 70-4.
42. Pirayesh A, Dessy LA, Rogge FJ, et al. The efficacy of a polyhydrated ionogen impregnated dressing in the treatment of recalcitrant diabetic foot ulcers: a multi-centre pilot study. Acta Chir Belg 2007; 107: 675-81.
43. Mulder GD, Patt LM, Sanders L, et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyll-lysine copper. Wound Repair Regen 1994; 2: 259-69.
44. Papanas N, Maltezos E, Edmonds M. The diabetic foot: a plea for the elementary? Acta Diabetol 2006; 43: 152-3.
45. Edmonds M, Bates M, Doxford M, Gough A, Foster A. New treatments in ulcer healing and wound infection. Diabetes Metab Res Rev 2000; 16 Suppl 1: S51-4.
46. Papanas N. Stem cell transplantation for the treatment of peripheral arterial disease. In: Gholamrezanezhad A, Editor. Stem cells in clinic and research, Tech open acess publisher, Rijeka 2011; pp.325-46.
47. O'Loughlin A, O'Brien T. Topical stem and progenitor cell therapy for diabetic foot ulcers. In: Gholamrezanezhad A, Editor. Stemcells in clinic and research, Tech open acess publisher, Rijeka 2011; pp. 579-604.
48. Kato J, Kamiya T, Shibata T, et al. Mesenchymal stem cells improve foot ulcer healing in diabetic rats. Diabetologia 2011; 54: Suppl 1: A 1169 [Abstract].
49. Tiaka EK, Papanas N, Manolakis AC, Maltezos E. The Role of Hyperbaric Oxygen in the Treatment of Diabetic Foot Ulcers. Angiology 2011 Aug 25. [Epub ahead of print].
50. van Houtum WH, Rauwerda JA, Ruwaard D, Schaper NC, Bakker K. Reduction in diabetes-related lower-extremity amputations inThe Netherlands: 1991-2000. Diabetes Care 2004; 27: 1042-6.